跳至主要内容
临床试验/NCT03226197
NCT03226197已完成不适用

Feasibility and Safety of Delivering a Ketone Drink to Comatose Survivors of Out-of-hospital Cardiac Arrest

Barts & The London NHS Trust1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2018年3月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
Change from baseline arterial blood gas values for pH

研究概览

简要总结

Every year, efforts are made to resuscitate about 30,000 people when their hearts stop outside of the hospital environment ('out-of-hospital cardiac arrest'). Early damage to the brain due to 'oxygen starvation' (seemingly paradoxically) gets worse when blood flow is restored. Of the 6,350 survivors admitted to intensive care units, 46% die from brain damage, and half of those who survive suffer long-term brain damage. Apart from avoiding a high temperature, nothing has been found which can protect the brain or improve outcome.

'Ketones' are chemicals naturally produced in the body from fat during starvation. They act as an energy source, but also as regulators of metabolism, and appear to protect cells from damage when oxygen supplies are scarce, or when blood flow is restored. The investigators want to see whether a ketone drink will protect the brain after out-of-hospital cardiac arrest.

The investigators will study 10 cardiac arrest patients, and participants will be given the ketone drink via a feeding tube (which is routinely passed into the stomach in such cases). The investigators shall check that the drink is absorbed, and measure the ketone levels in the blood. The investigators will also measure important aspects of blood chemistry (including pH and blood sugar) and collect data on brain (electrical recordings called 'EEG' and 'SSEP') and heart function (ultrasound scans or 'echocardiographs') - both of which it is hoped might improve - in order to demonstrate that this is possible if it is to be included in a subsequent large trial. The study will be scrutinised by world experts in the field, who have also helped design the study.

If this pilot study is a success, the investigators will apply to a major grant body to fund an appropriately-powered randomised controlled trial to determine whether ketones improve neurological outcome and survival in these patients. Results will also allow similar studies to be planned in heart attack, stroke and traumatic brain injury.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or above
  • Male or female
  • Comatose survivors of out-of-hospital cardiac arrest, defined as return of spontaneous circulation for at least 5 minutes with a score of <8 on the Glasgow Coma Scale
  • For admission to intensive care unit for full, active treatment

排除标准

  • Primary neurological or intracranial cause of cardiac arrest
  • In-hospital cardiac arrest
  • Inclusion in another trial at time of recruitment
  • Over 4 hours from time of return of spontaneous circulation to enrollment

结局指标

主要结局

Change from baseline arterial blood gas values for pH

时间窗: 48 hours

Change from baseline arterial blood gas value for bicarbonate (mmol/L),

时间窗: 48 hours

Change from baseline biochemistry laboratory results (full biochemistry panel including lipids, non-esterified fatty acids and serum insulin as per study protocol)

时间窗: 48 hours

Change from baseline arterial blood gas value for glucose (mmol/L)

时间窗: 48 hours

Change from baseline haematology laboratory results (full blood count and coagulation profile as per study protocol)

时间窗: 48 hours

Change from baseline arterial blood gas value for base excess (mEq/L),

时间窗: 48 hours

Change from baseline arterial blood gas value for lactate (mmol/L)

时间窗: 48 hours

Time from arrival of participant to ketone drink administration (hh:mm)

时间窗: 24 hours

Number of participants receiving full course of ketone drink

时间窗: 48 hours

As defined in study protocol: 25ml bolus followed after 1 hour by 47 hour infusion at 6 ml per hour

Change from baseline serum troponin (ng/ml)

时间窗: 12 hours

Change from baseline serum neuron specific enolase (ng/ml)

时间窗: 48 hours

次要结局

  • Change from baseline level of plasma betahydroxybutyrate (mmol/L)(48 hours)
  • Number of participants undergoing electroencephalogram as per protocol(72 hours)
  • Number of participants undergoing somatosensory evokes potentials as per protocol(72 hours)
  • Number of participants undergoing echocardiography as per protocol(72 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验